ロード中...
Management of T1 Urothelial Carcinoma of the Bladder: What Do We Know and What Do We Need To Know?
T1 bladder cancer constitutes approximately 25% of incident bladder cancers, and as such carries an important public health impact. Notably, it has a heterogeneous natural history, with large variation in reported oncologic outcomes. Optimal risk-stratification is essential to individualize patient...
保存先:
| 出版年: | Bl Cancer |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
IOS Press
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4927848/ https://ncbi.nlm.nih.gov/pubmed/27376120 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/BLC-150022 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|